Alvotech (ALVO) Long-Term Debt Repayments (2021 - 2026)

Alvotech (ALVO) posted Long-Term Debt Repayments of -$9.0 million for Q1 2026, down 216.89% on a QoQ basis from $7.7 million in Q3 2025, and down 153.89% year-over-year from $16.8 million in Q1 2025.

Alvotech (ALVO) Long-Term Debt Repayments (2021 - 2026) Analysis & Trends

Alvotech's Long-Term Debt Repayments history runs 6 years deep, the most recent figure standing at -$9.0 million for Q1 2026.

  • Quarterly Long-Term Debt Repayments fell 153.89% year-over-year to -$9.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$9.1 million (up 98.79% YoY) and the FY2023 annual result came in at -$99.4 million, down 1968.85% from the prior year.
  • Long-Term Debt Repayments was -$9.0 million for Q1 2026 at Alvotech, down from $7.7 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $75.8 million in Q3 2024 and bottomed at -$749.1 million in Q4 2024.
  • A 5-year average of -$81.3 million and a median of -$21.4 million in 2023 frame the typical range for Long-Term Debt Repayments.
  • Peak annual rise in Long-Term Debt Repayments reached 96.79% in 2024, while the deepest fall reached 653.85% in 2024.
  • Alvotech's Long-Term Debt Repayments stood at -$34.7 million in 2022, then plunged by 186.24% to -$99.4 million in 2023, then sank by 653.85% to -$749.1 million in 2024, then jumped by 101.03% to $7.7 million in 2025, then tumbled by 216.89% to -$9.0 million in 2026.
  • Business Quant data shows ALVO's Long-Term Debt Repayments at -$9.0 million in Q1 2026, $7.7 million in Q3 2025, and -$4.2 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 23.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -478.39 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Alvotech 935.87 Mn 935.87 Mn 5.09 Mn -9.05 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -9.05 Mn
Mar 31, 2026 -9.05 Mn
Sep 30, 2025 7.74 Mn
Sep 30, 2025 7.74 Mn
Jun 30, 2025 -4.19 Mn
Jun 30, 2025 -4.19 Mn
Mar 31, 2025 -3.56 Mn
Mar 31, 2025 -3.56 Mn
Dec 31, 2024 -749.08 Mn
Dec 31, 2024 -749.08 Mn
Sep 30, 2024 75.80 Mn
Sep 30, 2024 75.80 Mn
Jun 30, 2024 -73.43 Mn
Jun 30, 2024 -73.43 Mn
Mar 31, 2024 -1.63 Mn
Mar 31, 2024 -1.63 Mn
Dec 31, 2023 -99.37 Mn
Dec 31, 2023 -99.37 Mn
Jun 30, 2023 -33.70 Mn
Jun 30, 2023 -33.70 Mn